Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides

Identifieur interne : 000110 ( PascalFrancis/Checkpoint ); précédent : 000109; suivant : 000111

In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides

Auteurs : X. Zhou [Suède] ; L. Berg ; U. M. Abdel Motal ; M. Jondal

Source :

RBID : Pascal:93-0035362

Descripteurs français

English descriptors

Abstract

A primary cytotoxic T lymphocyte (CTL) response in vivo requires antigen presentation by cytosolic processing and can not in general be obtained by vaccination with soluble proteins. In the present work we have found that vaccination of mice with pre-processed synthetic peptides, corresponding to endogenous 9-mers produced in influenza A virus-infected cells, resulted in strong primary CTL responses. The generated CTL efficiently killed virus-infected target cells with preference for viral strains having the identical amino acid sequences to the peptides used for immunization


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:93-0035362

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides</title>
<author>
<name sortKey="Zhou, X" sort="Zhou, X" uniqKey="Zhou X" first="X." last="Zhou">X. Zhou</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Karolinska inst., dep. immunology</s1>
<s2>104 01 Stockholm</s2>
<s3>SWE</s3>
</inist:fA14>
<country>Suède</country>
<wicri:noRegion>104 01 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Berg, L" sort="Berg, L" uniqKey="Berg L" first="L." last="Berg">L. Berg</name>
</author>
<author>
<name sortKey="Abdel Motal, U M" sort="Abdel Motal, U M" uniqKey="Abdel Motal U" first="U. M." last="Abdel Motal">U. M. Abdel Motal</name>
</author>
<author>
<name sortKey="Jondal, M" sort="Jondal, M" uniqKey="Jondal M" first="M." last="Jondal">M. Jondal</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">93-0035362</idno>
<date when="1992">1992</date>
<idno type="stanalyst">PASCAL 93-0035362 INIST</idno>
<idno type="RBID">Pascal:93-0035362</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000111</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000103</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000110</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000110</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides</title>
<author>
<name sortKey="Zhou, X" sort="Zhou, X" uniqKey="Zhou X" first="X." last="Zhou">X. Zhou</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Karolinska inst., dep. immunology</s1>
<s2>104 01 Stockholm</s2>
<s3>SWE</s3>
</inist:fA14>
<country>Suède</country>
<wicri:noRegion>104 01 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Berg, L" sort="Berg, L" uniqKey="Berg L" first="L." last="Berg">L. Berg</name>
</author>
<author>
<name sortKey="Abdel Motal, U M" sort="Abdel Motal, U M" uniqKey="Abdel Motal U" first="U. M." last="Abdel Motal">U. M. Abdel Motal</name>
</author>
<author>
<name sortKey="Jondal, M" sort="Jondal, M" uniqKey="Jondal M" first="M." last="Jondal">M. Jondal</name>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of immunological methods</title>
<title level="j" type="abbreviated">J. immunol. methods</title>
<idno type="ISSN">0022-1759</idno>
<imprint>
<date when="1992">1992</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of immunological methods</title>
<title level="j" type="abbreviated">J. immunol. methods</title>
<idno type="ISSN">0022-1759</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Cytotoxicity</term>
<term>Immunization</term>
<term>In vivo</term>
<term>Induction</term>
<term>Influenzavirus A</term>
<term>Mouse</term>
<term>Peptides</term>
<term>Synthetic product</term>
<term>T-Lymphocyte</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Souris</term>
<term>Influenzavirus A</term>
<term>Lymphocyte T</term>
<term>Cytotoxicité</term>
<term>Immunisation</term>
<term>Peptide</term>
<term>Produit synthétique</term>
<term>Induction</term>
<term>In vivo</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A primary cytotoxic T lymphocyte (CTL) response in vivo requires antigen presentation by cytosolic processing and can not in general be obtained by vaccination with soluble proteins. In the present work we have found that vaccination of mice with pre-processed synthetic peptides, corresponding to endogenous 9-mers produced in influenza A virus-infected cells, resulted in strong primary CTL responses. The generated CTL efficiently killed virus-infected target cells with preference for viral strains having the identical amino acid sequences to the peptides used for immunization</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0022-1759</s0>
</fA01>
<fA02 i1="01">
<s0>JIMMBG</s0>
</fA02>
<fA03 i2="1">
<s0>J. immunol. methods</s0>
</fA03>
<fA05>
<s2>153</s2>
</fA05>
<fA06>
<s2>1-2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>ZHOU (X.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>BERG (L.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>ABDEL MOTAL (U. M.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>JONDAL (M.)</s1>
</fA11>
<fA14 i1="01">
<s1>Karolinska inst., dep. immunology</s1>
<s2>104 01 Stockholm</s2>
<s3>SWE</s3>
</fA14>
<fA20>
<s1>193-200</s1>
</fA20>
<fA21>
<s1>1992</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>15654</s2>
<s5>354000030004040230</s5>
</fA43>
<fA44>
<s0>0000</s0>
</fA44>
<fA45>
<s0>1 p.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>93-0035362</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i2="1">
<s0>Journal of immunological methods</s0>
</fA64>
<fA66 i1="01">
<s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>A primary cytotoxic T lymphocyte (CTL) response in vivo requires antigen presentation by cytosolic processing and can not in general be obtained by vaccination with soluble proteins. In the present work we have found that vaccination of mice with pre-processed synthetic peptides, corresponding to endogenous 9-mers produced in influenza A virus-infected cells, resulted in strong primary CTL responses. The generated CTL efficiently killed virus-infected target cells with preference for viral strains having the identical amino acid sequences to the peptides used for immunization</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002A06C05B</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Souris</s0>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Mouse</s0>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Ratón</s0>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Influenzavirus A</s0>
<s2>NW</s2>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Influenzavirus A</s0>
<s2>NW</s2>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Influenzavirus A</s0>
<s2>NW</s2>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Lymphocyte T</s0>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>T-Lymphocyte</s0>
<s6>«T»-Lymphocyte</s6>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Linfocito T</s0>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Cytotoxicité</s0>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Cytotoxicity</s0>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Citotoxicidad</s0>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Immunisation</s0>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Immunization</s0>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Inmunización</s0>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Peptide</s0>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Peptides</s0>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Péptido</s0>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Produit synthétique</s0>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Synthetic product</s0>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Producto sintético</s0>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Induction</s0>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Induction</s0>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Inducción</s0>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>In vivo</s0>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>In vivo</s0>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>In vivo</s0>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Influenzavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Influenzavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Influenzavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fN21>
<s1>354</s1>
</fN21>
</pA>
</standard>
</inist>
<affiliations>
<list>
<country>
<li>Suède</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Abdel Motal, U M" sort="Abdel Motal, U M" uniqKey="Abdel Motal U" first="U. M." last="Abdel Motal">U. M. Abdel Motal</name>
<name sortKey="Berg, L" sort="Berg, L" uniqKey="Berg L" first="L." last="Berg">L. Berg</name>
<name sortKey="Jondal, M" sort="Jondal, M" uniqKey="Jondal M" first="M." last="Jondal">M. Jondal</name>
</noCountry>
<country name="Suède">
<noRegion>
<name sortKey="Zhou, X" sort="Zhou, X" uniqKey="Zhou X" first="X." last="Zhou">X. Zhou</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000110 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000110 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:93-0035362
   |texte=   In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021